Considerations on the Application of RANO 2.0 Criteria in Clinical Practice.
作者信息
Meira Torcato
机构信息
Life and Health Sciences Research InstituteSchool of MedicineUniversity of Minho.
Neuroradiology DepartmentHospital de BragaBraga, Portugal.
出版信息
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):220. doi: 10.3174/ajnr.A8563.
Abstract
摘要
相似文献
1
Considerations on the Application of RANO 2.0 Criteria in Clinical Practice.
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):220. doi: 10.3174/ajnr.A8563.
2
RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology.
Jpn J Radiol. 2025 Jun 30. doi: 10.1007/s11604-025-01821-6.
3
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.
Neuro Oncol. 2025 Jan 12;27(1):77-88. doi: 10.1093/neuonc/noae208.
4
Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
Acta Neurochir (Wien). 2024 Apr 27;166(1):196. doi: 10.1007/s00701-024-06090-2.
5
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
AJNR Am J Neuroradiol. 2024 Dec 9;45(12):1846-1856. doi: 10.3174/ajnr.A8396.
6
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.
Neuro Oncol. 2025 Feb 10;27(2):557-566. doi: 10.1093/neuonc/noae205.
7
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Neuro Oncol. 2025 Jun 21;27(5):1341-1355. doi: 10.1093/neuonc/noae274.
8
Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline.
J Clin Sleep Med. 2025 Jan 1;21(1):137-152. doi: 10.5664/jcsm.11390.
9
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
10
C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET).
BMC Cancer. 2024 Jun 15;24(1):736. doi: 10.1186/s12885-024-12469-2.
引用本文的文献
1
RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology.
Jpn J Radiol. 2025 Jun 30. doi: 10.1007/s11604-025-01821-6.
本文引用的文献
1
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
AJNR Am J Neuroradiol. 2024 Dec 9;45(12):1846-1856. doi: 10.3174/ajnr.A8396.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
Zotero 插件